Sandu Pharmaceuticals, Inc. | Small-cap | Healthcare
₹48.85
0.99%
| Sandu Stock Comparison:
Sandu vs Sun PharmaceuticalSandu vs Divi's LaboratoriesSandu vs Sun Pharma AdvancedSandu vs Aarti DrugsSandu vs Sequent ScientificSandu vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 140.7M
Gross Profit 82.9M 58.93%
Operating Income 3.0M 2.15%
Net Income 3.3M 2.34%

Balance Sheet Metrics

Total Assets 557.2M
Total Liabilities 137.0M
Shareholders Equity 420.2M
Debt to Equity 0.33

Cash Flow Metrics

Revenue & Profitability Trend

Sandu Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i671.9M672.8M653.5M655.0M587.4M
Cost of Goods Sold i321.0M337.6M322.6M357.4M356.6M
Gross Profit i350.9M335.2M330.9M297.6M230.9M
Gross Margin % i52.2%49.8%50.6%45.4%39.3%
Operating Expenses
Research & Development i-1.1M1.2M1.6M1.4M
Selling, General & Administrative i-126.9M106.2M95.1M76.5M
Other Operating Expenses i214.1M81.1M85.4M179.7M48.6M
Total Operating Expenses i214.1M209.0M192.9M276.5M126.5M
Operating Income i20.9M17.1M19.7M23.4M16.0M
Operating Margin % i3.1%2.5%3.0%3.6%2.7%
Non-Operating Items
Interest Income i-1.6M1.6M763.0K1.9M
Interest Expense i1.0M543.0K721.0K1.1M647.0K
Other Non-Operating Income-----
Pre-tax Income i21.6M20.7M22.2M23.2M16.8M
Income Tax i6.1M6.1M7.0M7.3M5.9M
Effective Tax Rate % i28.1%29.5%31.4%31.4%35.0%
Net Income i15.5M14.6M15.2M15.9M10.9M
Net Margin % i2.3%2.2%2.3%2.4%1.9%
Key Metrics
EBITDA i29.3M27.1M28.1M29.6M23.0M
EPS (Basic) i-₹1.51₹1.62₹1.99₹1.54
EPS (Diluted) i-₹1.51₹1.62₹1.87₹1.54
Basic Shares Outstanding i-9660990881066479874377081000
Diluted Shares Outstanding i-9660990881066479874377081000

Income Statement Trend

Sandu Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i13.0M10.0M22.8M9.4M45.3M
Short-term Investments i13.5M2.0M200.0K32.3M71.3M
Accounts Receivable i47.6M48.7M47.9M39.9M53.5M
Inventory i141.5M122.5M143.3M112.7M111.4M
Other Current Assets47.4M1.0K1.8M3.9M-1.0K
Total Current Assets i263.0M223.0M255.4M236.5M305.4M
Non-Current Assets
Property, Plant & Equipment i181.2M113.1M110.8M109.8M109.8M
Goodwill i239.0K348.0K504.0K347.0K681.0K
Intangible Assets i239.0K348.0K504.0K347.0K681.0K
Long-term Investments-----
Other Non-Current Assets-1.0K-3.0K-11.0K-2.0K-2.0K
Total Non-Current Assets i294.2M301.1M286.2M256.4M164.2M
Total Assets i557.2M524.1M541.7M492.8M469.6M
Liabilities
Current Liabilities
Accounts Payable i44.9M42.3M84.4M68.6M67.5M
Short-term Debt i582.0K30.0K-0193.0K
Current Portion of Long-term Debt-----
Other Current Liabilities19.1M5.1M7.3M6.1M5.3M
Total Current Liabilities i120.9M106.4M138.8M118.7M125.2M
Non-Current Liabilities
Long-term Debt i4.2M603.0K---
Deferred Tax Liabilities i12.0M11.2M10.4M9.4M9.5M
Other Non-Current Liabilities--1.0K-1.0K-1.0K
Total Non-Current Liabilities i16.2M11.8M10.4M9.4M9.5M
Total Liabilities i137.0M118.2M149.3M128.1M134.7M
Equity
Common Stock i96.6M96.6M96.6M88.1M79.2M
Retained Earnings i-85.8M76.9M66.8M49.7M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i420.2M405.9M392.4M364.7M334.9M
Key Metrics
Total Debt i4.8M633.0K00193.0K
Working Capital i142.1M116.6M116.6M117.7M180.2M

Balance Sheet Composition

Sandu Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i21.6M20.7M22.2M23.2M16.8M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-16.2M29.8M-33.5M-12.7M48.3M
Operating Cash Flow i5.3M49.6M-12.2M10.8M64.4M
Investing Activities
Capital Expenditures i-9.4M-14.3M-10.7M-8.4M-1.3M
Acquisitions i-----
Investment Purchases i-28.0M-10.6M-4.0M-105.1M-68.1M
Investment Sales i34.4M10.2M18.5M58.0M11.6M
Investing Cash Flow i-3.0M-14.7M3.8M-55.5M-57.7M
Financing Activities
Share Repurchases i--7.2M-6.6M--
Dividends Paid i-7.7M-7.2M-6.6M-3.2M-
Debt Issuance i-----
Debt Repayment i-00-193.0K-12.3M
Financing Cash Flow i-7.7M-13.9M13.2M10.2M1.9M
Free Cash Flow i104.0K-6.7M-8.5M1.1M74.6M
Net Change in Cash i-5.4M21.1M4.8M-34.5M8.6M

Cash Flow Trend

Sandu Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 30.23
Price to Book 1.11
Price to Sales 0.70

Profitability Ratios

Profit Margin 2.41%
Operating Margin 2.08%
Return on Equity 3.69%
Return on Assets 2.78%

Financial Health

Current Ratio 2.18
Debt to Equity 1.14
Beta 0.20

Per Share Data

EPS (TTM) ₹1.60
Book Value per Share ₹43.77
Revenue per Share ₹69.12

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
sanduphq467.3M30.231.113.69%2.41%1.14
Sun Pharmaceutical 3.9T37.885.4515.08%19.29%3.26
Divi's Laboratories 1.6T70.4210.8814.64%23.89%0.03
Sun Pharma Advanced 45.5B-13.34-21.04157.88%-53.22%-1.24
Aarti Drugs 44.4B23.593.2512.28%7.80%44.92
Sequent Scientific 43.9B154.186.242.84%1.85%62.47

Financial data is updated regularly. All figures are in the company's reporting currency.